Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.0%

2 terminated out of 40 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

20%

8 trials in Phase 3/4

Results Transparency

29%

7 of 24 completed with results

Key Signals

7 with results92% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (15)
P 2 (2)
P 3 (4)
P 4 (4)

Trial Status

Completed24
Unknown7
Recruiting4
Not Yet Recruiting3
Terminated2

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT05463406Not ApplicableCompletedPrimary

Procalcitonin and Lung Ultrasonography Guided Antibiotherapy in Emergency Departments

NCT05110261Phase 3CompletedPrimary

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

NCT06788093Not ApplicableRecruitingPrimary

Reducing Overuse of Antibiotics With Decision Support

NCT05762302Not ApplicableRecruitingPrimary

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

NCT07279675Not Yet Recruiting

Clinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hospital

NCT07183553CompletedPrimary

The Effect of a Family-Centered Care Approach on Infants Receiving High-Flow Nasal Oxygen Therapy

NCT03694392Completed

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

NCT06210282Not ApplicableCompletedPrimary

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice

NCT03808922Phase 3RecruitingPrimary

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

NCT06016244Not ApplicableRecruiting

Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial

NCT06583317Not Yet Recruiting

Recurrent Pneumonia in Children

NCT06294899Not Yet Recruiting

CRP and Lung Ultrasound in Respiratory Evaluation

NCT04311320Not ApplicableCompleted

A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits

NCT06156436Completed

A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department

NCT03341273Not ApplicableTerminatedPrimary

Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level

NCT02454114Not ApplicableCompleted

HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections

NCT05374070Not ApplicableUnknownPrimary

Antiviral Activity of Oral Probiotics

NCT04233268UnknownPrimary

RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study

NCT03011515CompletedPrimary

Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)

NCT03846401UnknownPrimary

Bronchoscopy in Lower Respiratory Tract Infection in Respiratory Intensive Care Unit

Scroll to load more

Research Network

Activity Timeline